- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Imunon Inc (IMNN)
Imunon Inc stock price live, this page displays NASDAQ IMNN stock exchange data. View the IMNN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Imunon Inc real time stock price chart below.
What Is the Imunon Inc Stock Price Today?
The Imunon Inc stock price today is 1.5707.
What Is the Stock Symbol for Imunon Inc?
The stock ticker symbol for Imunon Inc is IMNN.
Is IMNN the Same as $IMNN?
$IMNN is a common way to refer to the Imunon Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Imunon Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNN quote. (ISIN: US15117N7012)
What Is the Imunon Inc Stock Price Today?
The Imunon Inc stock price today is 1.5707.
What Is the Stock Symbol for Imunon Inc?
The stock ticker symbol for Imunon Inc is IMNN.
Is IMNN the Same as $IMNN?
$IMNN is a common way to refer to the Imunon Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Imunon Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNN quote. (ISIN: US15117N7012)
1.5707
-0.0093(-0.59%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.5700
1.5900
52 wk Range
1.4700
6.9600
IMNN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.57001.5900
52 wk Range
1.47006.9600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMNN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
17.0000
Upside
+982.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K Imunon Inc For: 11 August- Investing.com
Form 4 Imunon Inc For: 21 July- Investing.com
- Form 8K Imunon Inc For: 11 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.0000
(+982.32% Upside)
Imunon Inc Earnings Call Summary for Q2/2026
- Imunon posted Q2 2026 loss of $0.54/share, beating analyst estimates of $0.93/share by 42%, though shares fell 0.61% to $1.62.
- Company secured $10M financing in June; current cash of $6.9M expected to fund operations only through end of 2026, requiring additional capital.
- Pivotal OVATION 3 trial enrollment exceeds plan at 0.5 patients/site/month vs. 0.3 assumed; primary analysis targeted for H1 2029.
- Operating cash burn improved 25% to $3.0M from $4.0M in Q1; R&D expenses rose to $1.5M while G&A costs fell 20% to $1.3M year-over-year.
- Lead candidate IMNN-001 showed 14.7-month survival improvement in Phase II with favorable safety profile; no revenue reported as company remains pre-commercial.
Last Updated: 08/11/2026, 11:57 AM
Read Full TranscriptEarnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.54 / -0.93
Revenue / Forecast
-- / --
Compare IMNN to Peers and Sector
Metrics to compare | IMNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −0.9x | −0.3x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price / Book | 4.6x | 1.6x | 2.6x | |
Price / LTM Sales | - | 4.2x | 3.1x | |
Upside (Analyst Target) | - | 225.5% | 50.4% | |
Fair Value Upside | Unlock | 6.5% | 6.4% | Unlock |
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company’s lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. In addition, the company develops non-viral DNA technology across modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Imunon (IMNN) Stock Price Today?
The Imunon stock price today is 1.5707 USD.
What Stock Exchange Does Imunon Trade On?
Imunon is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Imunon?
The stock symbol for Imunon is "IMNN."
What Is the Imunon Market Cap?
As of today, Imunon market cap is 8.8700M USD.
What Is Imunon's Earnings Per Share (TTM)?
The Imunon EPS (TTM) is -3.5691.
When Is the Next Imunon Earnings Date?
Imunon will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is IMNN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Imunon Stock Split?
Imunon has split 5 times.
How Many Employees Does Imunon Have?
Imunon has 20 employees.
What is the current trading status of Imunon (IMNN)?
As of Aug 19, 2026, Imunon (IMNN) is trading at a price of 1.5707 USD, with a previous close of 1.5800 USD. The stock has fluctuated within a day range of 1.5700 USD to 1.5900 USD, while its 52-week range spans from 1.4700 USD to 6.9600 USD.
What Is Imunon (IMNN) Price Target According to Analysts?
The average 12-month price target for Imunon is 17.0000 USD, with a high estimate of 25 USD and a low estimate of 10 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +982.32% Upside potential.
What Is the IMNN Premarket Price?
IMNN's last pre-market stock price is 1.6289 USD. The pre-market share volume is 2,230.0000, and the stock has decreased by 0.0489, or 3.0900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.